BioMarin Pharmaceuticals
BMRN
BMRN
510 hedge funds and large institutions have $13.6B invested in BioMarin Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 193 increasing their positions, 167 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $14.7B → $13.6B (-$1.11B)
18% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 57
45% less call options, than puts
Call options by funds: $80.7M | Put options by funds: $146M
Holders
510
Holding in Top 10
5
Calls
$80.7M
Puts
$146M
Top Buyers
| 1 | +$191M | |
| 2 | +$90.7M | |
| 3 | +$63.7M | |
| 4 |
Dodge & Cox
San Francisco,
California
|
+$56.5M |
| 5 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
+$46.7M |
Top Sellers
| 1 | -$350M | |
| 2 | -$75.3M | |
| 3 | -$71.9M | |
| 4 |
JP Morgan Chase
New York
|
-$65.2M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$48.9M |